(8 years, 10 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Order. Before I call Kate Osamor, if Members restrict their speeches to five or six minutes, we should have time for everyone who wants to speak. There is no formal time limit at this point.
It is a pleasure to serve under your chairmanship this morning, Mr Davies. Like others, I commend the hon. Member for Stafford (Jeremy Lefroy) on securing this debate and on the helpful way in which he set out the terms of the debate, which was helpful not least because, as the hon. Member for Congleton (Fiona Bruce) said, he covered all the technical terms and jargon, meaning that none of the rest of us has to go over those hurdles. I also pay tribute to the hon. Member for Stafford for his steadfast and sterling work as the chairman of the all-party parliamentary group on malaria and neglected tropical diseases. I try to attend the group’s meetings as often as I can, and I appreciate not only the quality of his work, but the calibre of the evidence and engagement that is brought to the group, which powerfully demonstrates the range of commitment of a number of charities and campaign groups. We have also heard directly from companies, not only about the quality of the work and their research, but about the commitment that they have been prepared to make on things such as price sensitivity. We have also been able to see and hear how important the work of DFID is and about its various partners in the NGO sector, and internationally and multilaterally.
The rate of progress and advance highlighted by the hon. Member for Stafford in his introduction in many ways proves the power of marshalled will when we have multilateral actions and well defined global goals. For some it is fashionable to knock such initiatives, but seeing real success against declared goals should incentivise us to do more and to go further. As the hon. Gentleman said, when we might still be looking at 450,000 or more children dying from malaria and neglected tropical diseases, we clearly need to do more.
This is a time for renewed commitment, rather than complacency about the challenges. Tackling malaria and neglected tropical diseases will be key to achieving the sustainable development goals, especially the health goal, the realisation of universal health coverage and the reduction in maternal and child mortality. Achievement of the global malaria targets by 2030 will mean more than 10 million lives saved, giving all that added productivity, releasing all that quality of life and increasing economic activity.
The UK should be seen to be prioritising sustainable development goal 3. We should therefore sustain and, I hope, increase the annual investment—£536 million at present—to achieve malaria elimination. The UK’s malaria and reproductive health framework for results will run out this year, so we need a renewed vision and a new plan for the UK’s contribution to global efforts towards elimination.
DFID has the credibility, so it should be seen to ensure that SDG 3 is more articulate about neglected tropical diseases by using its own working indicator on the number of people requiring interventions against neglected tropical diseases by 2030. Furthermore, we should heed the caution of the hon. Gentleman about silo approaches, which are understandable in the face of so many difficult challenges and so many pressures, but it is vital that we do not miss the opportunity to use disease-specific vertical programmes for other diseases and other health challenges to contribute towards the defeat of other diseases. It is therefore important for the UK to continue to fund bilateral, disease-specific programmes if we are to sustain the gains that have been made.
There has already been some discussion of “elimination” or “eradication”. It is important whether we use and how we qualify such terms and the differences between them. The goal is, in essence, one of emancipation. When we achieve elimination or eradication, we will have conquered a disease, with all the ravages that it can bring, including death, disability or diverting the life opportunities of those who have to care for the sufferers—women and children in poor countries are affected in particular. At the same time we will need to remember that malaria and neglected tropical diseases are not only a face of poverty, but a force for poverty, not least in their impact on women and children.
We need to see the whole effort as one of emancipation, creating alternatives for people—not only lives no longer lost, but lives that can be better lived and more fulfillingly expressed through economic contribution and in public life. That is why it is so timely that the hon. Member for Stafford has secured the debate and that is why it is so important that we encourage the Minister and everyone he works with in DFID to do everything that they can.
I was hoping to get two speakers in before 10.30 am, but I know that will be rather difficult.
Order. I need to call the Front-Bench Members now, as we have half an hour left and three 10-minute speeches to go, but I know that Dr Tania Mathias wanted to speak. Would you like to make a brief point?
Thank you, Mr Davies; I appreciate it. Contrary to some other people, I want to see 21st-century measures, with local medical teams and local Governments taking ownership.
The UK’s legacy is in data collection by the missionaries. In many of the countries in which I worked, that was not done adequately, and that is where the system will break down. Our greatest legacy is the rigour of data collection. I also commend the work of the late, great Colin McDougall, who was a titan in leprosy work. We owe him so much.
Mike Kane has indicated that he wants only five minutes, so if you want to speak for a couple of minutes, Dr Mathias, you may.
(13 years, 4 months ago)
Commons ChamberThe hon. Gentleman is absolutely right to speak up for his constituency, which could be affected by that review, as indeed could mine. We want to make sure that the review is as transparent as possible and involved and engaged with parents and with everyone in communities. There are many times, however, when rather bogus arguments are put forward for specialisation in the NHS, but, in a really complicated case such as child heart surgery, there are cases for specialisation, and, as passionately as we all want to defend our own hospitals, we have to think about clinical safety and what is best for children. He is absolutely right to speak up for his hospital, as I am for the one that serves my constituency, but we have to have some understanding about the complexity of what we are dealing with.
Does the Prime Minister understand that unilaterally setting the minimum price for carbon in Britain will drive out inward investors such as Tata Steel in Swansea? Carbon trading by its very nature requires a common price, not a unilateral one, so will he suspend that price and send his Chancellor into the European Union to negotiate a common price and ensure that we have a level playing field for inward investment?
I respect the hon. Gentleman’s views, but I do not agree with him. I think the steps taken in the Budget are right, and we should judge companies such as Tata by the investments that they make. I have been hugely heartened by the fact that Tata is putting more investment into the UK. Its Redcar plant closed under the previous Government, but it is going to reopen in part because of the investment that Tata is making. I will of course listen to the hon. Gentleman, but I think that Ratan Tata knows a bit more about his business than he does.
(13 years, 11 months ago)
Commons ChamberI thank my hon. Friend for his contribution. On his first point, all the money announced in New York—the second tranche, which is the doubling of our funding—is now being spent in Sindh and Punjab, for reasons that a number of hon. Members on both sides of the House have underlined.
My hon. Friend is right to identify the poor response, although while I was in New York there was a big increase in support from Saudi Arabia, Canada and Australia, and a number of other countries have followed since. I very much hope that at the European Union meetings taking place in the next fortnight, there will be a strong focus on ensuring that all the countries that can come to the assistance of Pakistan in its hour of need do what they can to help.
In respect of flood risk management in the future, to what extent will the UK Government support sustained investment in the adaptation of Pakistan to climate change, therefore making the country’s infrastructure and communities more resilient to future flooding?
The hon. Gentleman is absolutely right to talk about the importance of ensuring that there is effective investment in flood defences. It is something that the international community and the Government of Pakistan will want to look at in all three of the phases I described.